Inventor
Maria Calderon-Cacia
Inventor
Castro Valley, CA, US
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
C12NMicroorganisms or enzymes15%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms15%
C12YEnzymes15%
G01NInvestigating or analysing materials by determining their chemical or physical properties15%
A61KPreparations for medical, dental or toiletry purposes8%
C07KPeptides8%
PatentTitleYear
9,926,371'M-CSF specific monoclonal antibody and uses thereof'20189,522,186'M-CSF specific monoclonal antibody and uses therof'20169,079,956'M-CSF specific monoclonal antibody and uses thereof'20157,807,430'GSK3 polypeptides'20107,361,484'GSK3 polypeptides'20087,195,886'GSK3 polypeptides'20077,135,321'GSK3 polypeptides'20066,716,624'GSK3 polypeptides'20046,465,231'GSK3 polypeptides'2002Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2002–2008Patents assigned to CHIRON CORP (5)· patent assignee history
2002–2018Based in Castro Valley, CA, US· patent location history
2010–2015Patents assigned to NOVARTIS VACCINES & DIAGNOSTIC (2)· patent assignee history
2015–2018Patents assigned to XOMA TECHNOLOGY LTD (3)· patent assignee history
2016–2018Patents assigned to NOVARTIS VACCINES & DIAGNOSTICS INC (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CHIRON CORP | 5 | 2002–2008 |
| XOMA TECHNOLOGY LTD | 3 | 2015–2018 |
| NOVARTIS VACCINES & DIAGNOSTIC | 2 | 2010–2015 |
| NOVARTIS VACCINES & DIAGNOSTICS INC | 2 | 2016–2018 |
Locations
| Location | Patents | Span |
|---|---|---|
| Castro Valley, California, US | 9 | 2002–2018 |